Laboratory for Cell and Gene Medicine
Stanford's GMP Facility
Stanford Laboratory for Cell and Gene Medicine (LCGM) is a state-of-the-art CGMP facility supporting clinical investigators during early phase, pre-clinical development through clinical manufacturing for first in-human therapies. Our mission is to develop innovative manufacturing platforms for the GMP manufacture of cell and gene therapy products enabling Stanford investigators to bridge the “bench to bedside” gap for treating patients with large unmet medical needs.
Service Offerings:
Stanford LCGM
855 California Ave., St's B&C
Palo Alto, CA 94304
Investing in the Future: CIRM Infrastructure Award
LCGM received $2M from CIRM for its Phase One Initiative to build a California Cell and Gene Therapy Manufacturing Network; Steve Feldman, PhD, LCGM's Site Head and Scientific Director is the Principal Investigator. Read more here